{"product_id":"cancer-consult-expertise-in-clinical-practice-volume-1-9781119823735","title":"Cancer Consult Expertise in Clinical Practice","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eEditors Volume 1 xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eVolume 2: Neoplastic Hematology \u0026amp; Cellular Therapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEditors xii\u003c\/p\u003e \u003cp\u003eEditor's Biography xiii\u003c\/p\u003e \u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eAcknowledgment xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Central Nervous System 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Central Nervous System Tumors 3\u003cbr\u003e\u003ci\u003eMark R. Gilbert and Edina Komlodi-Pasztor\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Head and Neck and Thoracic Cancers 13\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2 Localized Head and Neck Cancer 15\u003cbr\u003e\u003ci\u003eEmrullah Yilmaz and Jessica L. Geiger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Recurrent and Metastatic Head and Neck Cancer 31\u003cbr\u003e\u003ci\u003eChloe Weidenbaum and Mike Gibson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Thyroid Cancers 39\u003cbr\u003e\u003ci\u003eKartik Sehgal and Jochen H. Lorch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Non-Small Cell Lung Cancer: Screening, Staging, and Stage I 51\u003cbr\u003e\u003ci\u003eRyan D. Gentzler and Linda W. Martin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Non-Small Cell Lung Cancer: Stages II and III 63\u003cbr\u003e\u003ci\u003eGregory Peter Kalemkerian, Kamya Sankar, and Angel Qin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Recurrent and Metastatic Non-Small Cell Lung Cancer 79\u003cbr\u003e\u003ci\u003eJulia Judd, J. Nicholas Bodor, and Hossein Borghaei\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Small Cell Lung Cancer 97\u003cbr\u003e\u003ci\u003eJyoti D. Patel and Husam Hafzah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Mesothelioma 105\u003cbr\u003e\u003ci\u003eHarvey I. Pass, David Chen, and Jack Donaghue\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Breast Cancer 115\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10 DCIS and LCIS 117\u003cbr\u003e\u003ci\u003eAmanda Nash, Rita Mukhtar, and Shelley Hwang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Early-Stage ER\/PR –Positive, HER2-Negative Breast Cancer 129\u003cbr\u003e\u003ci\u003eWilliam J. Gradishar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 ER\/PR-Positive, HER2-Negative Metastatic Breast Cancer 139\u003cbr\u003e\u003ci\u003eSara Nunnery, Laura Kennedy, and Sonya Reid\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Early-Stage HER2-Positive Breast Cancer 151\u003cbr\u003e\u003ci\u003eErin Roesch and Jame Abraham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 HER2-Positive Metastatic Breast Cancer 163\u003cbr\u003e\u003ci\u003eReshma L. Mahtani, Naomi G. Dempsey, and Ana Sandoval\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Early-Stage Triple-Negative Breast Cancer 179\u003cbr\u003e\u003ci\u003eTiffany A. Traina, Carlos dos Anjos, and Elaine Walsh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Triple-Negative Metastatic Breast Cancer 191\u003cbr\u003e\u003ci\u003eAzadeh Nasrazadani, Juan Gomez, and Adam Brufsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Inflammatory Breast Cancer – A Distinct Entity 201\u003cbr\u003e\u003ci\u003eMassimo Cristofanilli and Elena Vagia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Male Breast Cancer 213\u003cbr\u003e\u003ci\u003eLaura A. Huppert, Ozge Gumusay, Shreya Desai, and Hope S. Rugo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Breast Cancer in Pregnancy and Fertility Preservation 225\u003cbr\u003e\u003ci\u003eFedro A. Peccatori, Hatem Azim, and Matteo Lambertini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Gastrointestinal Cancers 233\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e20 Early-Stage Gastroesophageal Cancer and Precursor Lesions 235\u003cbr\u003e\u003ci\u003eYixing Jiang and Aaron Ciner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Metastatic Esophagogastric Cancer 249\u003cbr\u003e\u003ci\u003eGeoffrey Y. Ku and David H. Ilson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Early-Stage Colon Cancer 255\u003cbr\u003e\u003ci\u003eJohn Krauss, Vaibhav Sahai, and Al B. Benson III\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Early-Stage Rectal Cancer 267\u003cbr\u003e\u003ci\u003eHannah J. Roberts, Theodore Hong, and Aparna Parikh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Recurrent and Metastatic Colorectal Cancer 283\u003cbr\u003e\u003ci\u003eJoseph Heng and Blase Polite\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Pancreatic Adenocarcinoma 291\u003cbr\u003e\u003ci\u003eEvan Walker, Andrew Ko, and Margaret Tempero\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Hepatocellular Cancer 309\u003cbr\u003e\u003ci\u003ePedro Luiz Serrano Uson Junior and Mitesh Borad\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Biliary Tract Cancers 319\u003cbr\u003e\u003ci\u003eDavid B. Zhen and Vaibhav Sahai\u003c\/i\u003e\u003c\/p\u003e 28 Carcinoid and Neuroendocrine Tumors 327\u003cbr\u003e\u003ci\u003eMintallah Haider and Jonathan Strosberg\u003c\/i\u003e \u003cp\u003e29 Anal Cancer 343\u003cbr\u003e\u003ci\u003eAsad Mahmood and Rob Glynne-Jones\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Genitourinary Cancers 359\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e30 Renal Cancer 361\u003cbr\u003e\u003ci\u003eJames L. Coggan, Alan Tan, and Timothy M. Kuzel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 Bladder Cancer 375\u003cbr\u003e\u003ci\u003eRevathi Kollipara, Alan Tan, and Timothy M. Kuzel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Prostate Cancer: Screening, Surveillance, Prognostic Algorithms, and Independent Pathologic Predictive Parameters 389\u003cbr\u003e\u003ci\u003eEduardo Benzi and Thomas M. Wheeler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Early and Locally Advanced Prostate Cancer 399\u003cbr\u003e\u003ci\u003eJames Randall, Mohammad R. Siddiqui, Ashley Ross, and Sean Sachdev\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Metastatic Prostate Cancer 421\u003cbr\u003e\u003ci\u003ePriyanka Chablani, Natalie Reizine, and Walter Stadler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Germ Cell Tumors 437\u003cbr\u003e\u003ci\u003eHamid Emamekhoo, Syed A. Abutalib, and Timothy Gilligan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 6 Skin Malignancies 453\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e36 Melanoma 455\u003cbr\u003e\u003ci\u003eAna M. Ciurea and Kim Margolin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Nonmelanoma Skin Cancers 477\u003cbr\u003e\u003ci\u003eChrysalyne D. Schmults and Danielle A. Parker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 7 Gynecological Cancers 497\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e38 Ovarian Cancer: Primary Treatment and Approach to Recurrent Disease 499\u003cbr\u003e\u003ci\u003eRani Bansal, Don Dizon, and Martina Murphy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Ovarian Cancer: Second-line Treatment Strategies 511\u003cbr\u003e\u003ci\u003eMaurie Markman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Endometrial Cancer 523\u003cbr\u003e\u003ci\u003eMaurie Markman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Cancer of the Cervix, Vulva, and Vagina 533\u003cbr\u003e\u003ci\u003eSabrina M. Bedell and Peter G. Rose\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Uncommon Gynecologic Cancers 549\u003cbr\u003e\u003ci\u003eMichael Frumovitz, Shannon Westin, and David M. Gershenson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 8 Sarcomas 565\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e43 Bone Sarcomas 567\u003cbr\u003e\u003ci\u003eNicole Larrier, William Eward, and Richard F. Riedel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Soft Tissue Sarcomas 579\u003cbr\u003e\u003ci\u003eJeffrey Farma, Krisha Howell, and Margaret von Mehren\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 9 Hereditary Cancer Syndromes and Genetic Testing 595\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e45 Hereditary Cancer Syndromes 597\u003cbr\u003e\u003ci\u003eMary B. Daly\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Hereditary Breast and Ovarian Cancer Syndromes 611\u003cbr\u003e\u003ci\u003eKristen Whitaker and Elias Obeid\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Hereditary Gastrointestinal and Pancreatic Cancer Syndromes 625\u003cbr\u003e\u003ci\u003eKristen M. Shannon, Linda H. Rodgers-Fouche, and Daniel C. Chung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 10 Special Issues in Oncology 637\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e48 Cancer of Unknown Primary 639\u003cbr\u003e\u003ci\u003eTony Greco\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Anticoagulation in Cancer 651\u003cbr\u003e\u003ci\u003eJean Marie Connors\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Identification and Management of Immunotherapy-Related Adverse Events in Oncology 663\u003cbr\u003e\u003ci\u003eOzge Gumusay, Laura A. Huppert, Dame Idossa, and Hope S. Rugo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Geriatric Oncology 677\u003cbr\u003e\u003ci\u003eSukeshi Patel Arora and Efrat Dotan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 Palliative Medicine for Curable and Terminal Cancers 693\u003cbr\u003e\u003ci\u003eIsabelle Blanchard, Kavitha Jennifer Ramachandran, and Divya Gupta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 709\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49407163433303,"sku":"9781119823735","price":99.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119823735.jpg?v=1730498393","url":"https:\/\/bookcurl.com\/products\/cancer-consult-expertise-in-clinical-practice-volume-1-9781119823735","provider":"Book Curl","version":"1.0","type":"link"}